Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | IFI16 |
| Upstream (Parents) |
|---|
| (<<) CSF2RB → IFI16 |
| (<<) RAB31 → IFI16 |
| (<<) CLEC7A → IFI16 |
| Downstream (Children) |
|---|
| IFI16 → RAB40C (>>) |
| IFI16 → IL26 (>>) |
| IFI16 → HLA-DOB (>>) |
| IFI16 → PTGER3 (>>) |
| IFI16 → C21orf96 (>>) |
| IFI16 → ZP2 (>>) |
| IFI16 → AIM2 (>>) |
| IFI16 → NFKBIL1 (>>) |
| IFI16 → NCF4 (>>) |
| IFI16 → MCTP1 (>>) |
| IFI16 → BIRC3 (>>) |
| IFI16 → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 (>>) |
| IFI16 → SAMD9 (>>) |
| IFI16 → ICAM2 (>>) |
| IFI16 → HLA-DRB1 (>>) |
| IFI16 → BATF3 (>>) |
